November 6, 2014 5:58 AM
The Return of the Debate: Are or Should Human Genes be Patentable?
Ever since Myriad’s famous patents on the BRCA 1 and BRCA 2 genes and its assertive patent-oriented business strategies around the world, the matter of whether gene patents are or should be legal has been profusely discussed. This discussion has in fact brought about the publication of a number of peer reviewed articles and reports1, the development of policies and guidelines2, the public awareness as part of the Angelina effect, and even recently, the courts involvement and pronouncement in the U.S., Australia, and now Canada.
This week, the Children’s Hospital of Eastern Ontario (CHEO) started a legal process to challenge the legality of human gene patents before the Federal Court in Canada.